224 related articles for article (PubMed ID: 20969909)
1. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.
Ghandri N; Gabbouj S; Farhat K; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L; Hassen E
Hum Immunol; 2011 Feb; 72(2):150-8. PubMed ID: 20969909
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.
Hassen E; Ghedira R; Ghandri N; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L
DNA Cell Biol; 2011 Aug; 30(8):603-9. PubMed ID: 21332388
[TBL] [Abstract][Full Text] [Related]
3. HLA-E polymorphism in patients with nasopharyngeal carcinoma.
Hirankarn N; Kimkong I; Mutirangura A
Tissue Antigens; 2004 Nov; 64(5):588-92. PubMed ID: 15496202
[TBL] [Abstract][Full Text] [Related]
4. Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians.
Li X; Ghandri N; Piancatelli D; Adams S; Chen D; Robbins FM; Wang E; Monaco A; Selleri S; Bouaouina N; Stroncek D; Adorno D; Chouchane L; Marincola FM
J Transl Med; 2007 May; 5():22. PubMed ID: 17480220
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
6. Associations of Human Leukocyte Antigen-DRB1 Alleles with Nasopharyngeal Carcinoma and Its Clinical Significance in Xinjiang Uyghur Autonomous Region of China.
Geng XT; Hu YH; Dong T; Wang RZ
Chin Med J (Engl); 2016 Jun; 129(11):1347-54. PubMed ID: 27231174
[TBL] [Abstract][Full Text] [Related]
7. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
8. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression.
Nasr HB; Chahed K; Bouaouina N; Chouchane L
Clin Chim Acta; 2008 Sep; 395(1-2):124-9. PubMed ID: 18588866
[TBL] [Abstract][Full Text] [Related]
9. HLA association with nasopharyngeal carcinoma in southern Tunisia.
Makni H; Daoud J; Ben Salah H; Mahfoudh N; Haddar O; Karray H; Boudawara T; Ghorbel A; Khabir A; Frikha M
Mol Biol Rep; 2010 Jun; 37(5):2533-9. PubMed ID: 19714482
[TBL] [Abstract][Full Text] [Related]
10. The CC-genotype of the cyclooxygenase-2 gene associates with decreased risk of nasopharyngeal carcinoma in a Tunisian population.
Mamoghli T; Douik H; Mehri S; Ghanem A; Ben Chaabane A; Bouassida J; Kablouti G; Harzallah L; Gritli S; Guemira F
Pathol Biol (Paris); 2015 Feb; 63(1):7-10. PubMed ID: 25438689
[TBL] [Abstract][Full Text] [Related]
11. Are HLA-E*0103 alleles predictive markers for nasopharyngeal cancer risk?
Douik H; Romdhane NA; Guemira F
Pathol Res Pract; 2016 Apr; 212(4):345-9. PubMed ID: 26896927
[TBL] [Abstract][Full Text] [Related]
12. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
13. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients.
Farhat K; Hassen E; Bouzgarrou N; Gabbouj S; Bouaouina N; Chouchane L
Cytokine; 2008 Aug; 43(2):132-7. PubMed ID: 18555694
[TBL] [Abstract][Full Text] [Related]
14. The xeroderma pigmentosum group C gene polymorphisms and genetic susceptibility of nasopharyngeal carcinoma.
Yang ZH; Liang WB; Jia J; Wei YS; Zhou B; Zhang L
Acta Oncol; 2008; 47(3):379-84. PubMed ID: 17882560
[TBL] [Abstract][Full Text] [Related]
15. Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China.
Tian W; Zhu FM; Wang WY; Cai JH; Zhang W; Li LX; Liu KL; Jin HK; Wang F
Tissue Antigens; 2015 Jul; 86(1):15-20. PubMed ID: 25940993
[TBL] [Abstract][Full Text] [Related]
16. Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.
Ban EZ; Lye MS; Chong PP; Yap YY; Lim SYC; Abdul Rahman H
PLoS One; 2017; 12(11):e0187200. PubMed ID: 29121049
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Nitric oxide synthase 3 genetic variants to nasopharyngeal carcinoma risk and progression in a Tunisian population.
Aouf S; Laribi A; Gabbouj S; Hassen E; Bouaouinaa N; Zakhama A; Harizi H
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1231-1239. PubMed ID: 30758659
[TBL] [Abstract][Full Text] [Related]
18. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
[TBL] [Abstract][Full Text] [Related]
19. [Association of MnSOD single nucleotide polymorphism with the occurrence and clinical outcome of nasopharyngeal carcinoma in Cantonese].
Ye E; Zhang Y; Wang H; Shi Y; Chen L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):798-801. PubMed ID: 22699057
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
